Molecule Details
| InChIKey | DEQITUUQPICUMR-HJPBWRTMSA-N |
|---|---|
| Compound Name | Dihydroergocristine |
| Canonical SMILES | CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 13 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.98 |
| Source | ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB13345 |
|---|---|
| Drug Name | Dihydroergocristine |
| CAS Number | 17479-19-5 |
| Groups | approved |
| ATC Codes | C04AE54 C04AE04 |
| Description | Dihydroergocristine is part of the ergoloid mixture products.[L2637] It is a semisynthetic ergot alkaloid and thus, it is characterized by a structural skeleton formed by an alkaloid ergoline.[A32879] To know more about ergoloid mixtures, please visit [DB01049]. |
Categories: Adrenergic Agents Adrenergic Antagonists Agents that produce hypertension Alkaloids BSEP/ABCB11 Substrates Cardiovascular Agents Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A4 Substrates (strength unknown) Cytochrome P-450 Substrates Ergot Alkaloids and Derivatives Ergotamines Heterocyclic Compounds, Fused-Ring Neurotransmitter Agents Peripheral Vasodilators Vasodilating Agents
Cross-references: BindingDB: 50390992 ChEBI: 59912 CHEMBL601773 ChemSpider: 96884 D07834 RxCUI: 3416 Wikipedia: Dihydroergocristine ZINC: ZINC000003995616
Target Activities (13)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P14416 | DRD2 | Homo sapiens | Human | PF00001 | 9.1 | IC50 | ChEMBL |
| P08913 | ADRA2A | Homo sapiens | Human | PF00001 | 8.9 | IC50 | ChEMBL |
| P35462 | DRD3 | Homo sapiens | Human | PF00001 | 8.9 | IC50 | ChEMBL |
| P07550 | ADRB2 | Homo sapiens | Human | PF00001 | 8.6 | Ki | ChEMBL |
| P18825 | ADRA2C | Homo sapiens | Human | PF00001 | 8.5 | IC50 | ChEMBL |
| P25100 | ADRA1D | Homo sapiens | Human | PF00001 | 8.3 | IC50 | ChEMBL |
| P41595 | HTR2B | Homo sapiens | Human | PF00001 | 8.3 | IC50 | ChEMBL |
| P18089 | ADRA2B | Homo sapiens | Human | PF00001 | 8.3 | IC50 | ChEMBL |
| P28223 | HTR2A | Homo sapiens | Human | PF00001 | 8.1 | IC50 | ChEMBL |
| P50406 | HTR6 | Homo sapiens | Human | PF00001 | 7.5 | IC50 | ChEMBL |
| P28335 | HTR2C | Homo sapiens | Human | PF00001 | 6.8 | IC50 | ChEMBL |
| P35372 | OPRM1 | Homo sapiens | Human | PF00001 | 6.3 | IC50 | ChEMBL |
| P21728 | DRD1 | Homo sapiens | Human | PF00001 | 6.2 | Ki | ChEMBL |
DrugBank Target Actions (10)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P08684 | CYP3A4 | Cytochrome P450 3A4 | substrate | enzymes |
| P08588 | ADRB1 | Beta adrenergic receptor | agonist | targets |
| P21728 | DRD1 | Dopamine receptor | agonist | targets |
| P35348 | ADRA1A | Alpha adrenergic receptor | agonist | targets |
| P08588 | ADRB1 | Beta adrenergic receptor | antagonist | targets |
| P08908 | HTR1A | Serotonin Receptors | antagonist | targets |
| P21728 | DRD1 | Dopamine receptor | antagonist | targets |
| P35348 | ADRA1A | Alpha adrenergic receptor | antagonist | targets |
| P18825 | ADRA2C | Alpha-2C adrenergic receptor | modulator | targets |
| O95342 | ABCB11 | Bile salt export pump | substrate | transporters |